Of note, HDAC inhibitors have been known for a long time as successful anticancer agents as they specifically induce cell cycle arrest and apoptosis in “abnormal” cancer cells, whereas normal healthy cells are relatively resistant to HDAC-inhibitor-induced cell death [172,173]. This evidence concerns the gene HDAC9 and cancer.